Exercise of Nil Cost Options under PSP

Assura PLC

12 July 2024

 

12 July 2024

Assura plc

("the Company")

Exercise of Nil Cost Options under PSP

Assura plc ("Assura"), the specialist healthcare property investor and developer announces that on 10 July 2024, the PDMRs listed below exercised their 2021 PSP awards.

The table below shows the number of shares vesting, the number of shares sold to satisfy income tax and national insurance liabilities, the number of shares sold for the benefit of the Assura Community Fund and the number of shares received following the sales.

	Number of shares awarded	Number of shares sold to satisfy income tax and national insurance liabilities	Additional shares sold on behalf of the Assura Community Fund	Additional shares sold	Number of shares after shares sold
Jonathan Murphy	392,165	184,317	39,217	-	168,631
Jayne Cottam	220,406	103,591	-	-	116,815
Orla Ball	52,903	24,864	-	28,039	-

The Remuneration Committee of Assura had agreed that sufficient shares may be sold by each PDMR to cover the arising income tax and national insurance liabilities, that Mr Murphy could sell 39,217 shares to make a contribution to the Assura Community Fund and that Ms Ball could sell the balances of her restricted shares in full. The relevant market price for taxation purposes is £0.4229 per share.

As a result of the above, the PDMR's shareholding and those of their connected persons is as follows:

	Shareholding on 9 July 2024	Shareholding post exercise
Jonathan Murphy	3,149,294	3,317,925
Jayne Cottam	826,255	943,070
Orla Ball	29,768	29,768

Following the allotment, Mr Murphy & Ms Cottam transferred 168,630 and 116,815 shares respectively to their spouse. The total beneficial holding remains the same.

The Notification of Dealing Forms can be found below.

This notification is made in accordance with the Market Abuse Regulation.

Notification of dealing form

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Jonathan Murphy
2	Reason for the notification
a)	Position/status	CEO
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Vesting of share awards under PSP
c)	Price(s) and volume(s)	Price(s) Volume(s) £NIL GBP 392,165
d)	Aggregated information -      Aggregated volume -    Price	N/A
e)	Date of the transaction	10/07/2024
f)	Place of the transaction	XLON
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Sale of shares to satisfy tax and national insurance liabilities and to make a contribution to the Assura Community Fund.
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.4229 GBP 223,534
d)	Aggregated information -      Aggregated volume -    Price	Aggregate Price Aggregate Volume Aggregate Total £0.4229 GBP 223,534 £94,532.53 GBP
e)	Date of the transaction	10/07/2024
f)	Place of the transaction	XLON
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Transfer shares to Mr Murphy's spouse
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.4229 GBP 168,631
d)	Aggregated information -      Aggregated volume -    Price	Aggregate Price Aggregate Volume Aggregate Total £0.4229 GBP 168,631 £71,314.05 GBP
e)	Date of the transaction	10/07/2024
f)	Place of the transaction	XLON

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Jayne Cottam
2	Reason for the notification
a)	Position/status	CFO
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Vesting of share awards under PSP
c)	Price(s) and volume(s)	Price(s) Volume(s) £NIL GBP 220,406
d)	Aggregated information -      Aggregated volume -    Price	N/A
e)	Date of the transaction	10/07/2024
f)	Place of the transaction	XLON
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Sale of shares to satisfy tax and national insurance liabilities.
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.4229 GBP 103,591
d)	Aggregated information -      Aggregated volume -    Price	Aggregate Price Aggregate Volume Aggregate Total £0.4229 GBP 103,591 £43,808.64 GBP
e)	Date of the transaction	10/07/2024
f)	Place of the transaction	XLON
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Transfer shares to Ms Cottam's spouse
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.4229 GBP 116,815
d)	Aggregated information -      Aggregated volume -    Price	Aggregate Price Aggregate Volume Aggregate Total £0.4229 GBP 116,815 £49,401.06 GBP
e)	Date of the transaction	10/07/2024
f)	Place of the transaction	XLON

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Orla Ball
2	Reason for the notification
a)	Position/status	General Counsel
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Vesting of restricted share awards under PSP
c)	Price(s) and volume(s)	Price(s) Volume(s) £NIL GBP 52,903
d)	Aggregated information -      Aggregated volume -    Price	N/A
e)	Date of the transaction	10/07/2024
f)	Place of the transaction	XLON
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Sale of shares to satisfy tax and national insurance liabilities.
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.4229 GBP 24,864
d)	Aggregated information -      Aggregated volume -    Price	Aggregate Price Aggregate Volume Aggregate Total £0.4229 GBP 24,864 £10,514.99 GBP
e)	Date of the transaction	10/07/2024
f)	Place of the transaction	XLON
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Sale of shares
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.4229 GBP 28,039
d)	Aggregated information -      Aggregated volume -    Price	Aggregate Price Aggregate Volume Aggregate Total £0.4229 GBP 28,039 £11,857.69 GBP
e)	Date of the transaction	10/07/2024
f)	Place of the transaction	XLON

- Ends -

For more information, please contact:

Assura plc	Tel: [phone]
Orla Ball, General Counsel David Purcell, Investor Relations Director	Email: [e-mail]
FGS Global Gordon Simpson Grace Whelan	Tel: [phone] Email: [e-mail]

Notes to Editors

Assura plc is the UK's leading specialist healthcare property investor and developer. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders.

At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

 

END